Exploring SSR1 as a novel diagnostic and prognostic biomarker in hepatocellular carcinoma, and its relationship with immune infiltration

SSR1 surfaces as a new diagnostic and potentially prognostic biomarker, showing an association with immune cell infiltration and cell proliferation in HCC.

Authors

Institutions

Publication Details

Journal
Translational Cancer Research
Published
2024-10-01
DOI
https://doi.org/10.21037/tcr-24-277
Citations
6
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
2.51
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring SSR1 as a novel diagnostic and prognostic biomarker in hepatocellular carcinoma, and its relationship with immune infiltration

Qingyu Xiao, Zhen Cheng, Haijun Wu, Wen‐Ying Shen et al.
6 citations
Translational Cancer Research
Ferroptosis and cancer prognosis
2.51
article

Exploring SSR1 as a novel diagnostic and prognostic biomarker in hepatocellular carcinoma, and its relationship with immune infiltration

Qingyu Xiao, Zhen Cheng, Haijun Wu, Wen‐Ying Shen, Wen Qü
article en
6 citations

Abstract

SSR1 surfaces as a new diagnostic and potentially prognostic biomarker, showing an association with immune cell infiltration and cell proliferation in HCC.

Translational Cancer ResearchVol. 13(10)
Shenzhen Bao'an District People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 10%
Ferroptosis and cancer prognosis
2.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.